Objectives: This study examined the homeostatic parameters possibly related to HIV-infected patients who, despite being under suppressive highly active antiretroviral therapy (HAART), show low-level CD4 T cell repopulation (LLR).
Introduction
A proportion of highly active antiretroviral therapy (HAART)-treated subjects experience no significant increase in CD4 T cell levels despite optimum suppression of plasma HIV-1 viraemia. 1 Among these patients, we have previously defined those whose CD4 T cell levels persistently remain ,250 cells/mm 3 as low-level CD4 T cell repopulation HIV-infected subjects (LLR patients).
2, 3 We, as well as others, have shown that LLR patients possess an increased risk of clinical progression and death, 3 -5 but, to date, therapeutic alternatives for LLR patients are not available. In fact, interleukin-2 (IL-2) therapy does not yield clinical improvement despite moderate increases in CD4 T cell levels. 6 The underlying mechanisms for this low-level repopulation are still not fully understood. 7 An increased apoptosis of uninfected cells, 8 a lack of redistribution from secondary lymphoid organs, 9 a poor proliferative capacity of peripheral CD4 T 11 and a higher frequency of CXCR4-using viruses 12 have all been described as possible explanations for this phenomenon. A higher plasma IL-7 concentration has also been shown in these patients, 13, 14 although the expression of the IL-7 receptor is still controversial. 13, 14 More recent studies have proposed that bacterial translocation is involved in CD4 T cell restoration under suppressive HAART. 15, 16 In a recent report that analysed several surrogate markers of microbial translocation, only soluble CD14 (sCD14) was independently associated with mortality in HIV infection. 17 Indeed, 13 years ago, it was anticipated that sCD14 correlated with the progression of HIV infection. 18 We considered whether sCD14 levels could somehow explain the worse progression and enhanced risk of death in LLR patients. 3 -5 On the other hand, immune activation and systemic inflammation could be interconnected; 19 however, to our knowledge, no previous reports have considered the inflammatory status of LLR patients.
We recently reported a model in which the reduction of thymic function could cause a disturbance in the peripheral homeostasis of CD4 T cell subsets and, thus, promote a premature immunosenescence. 2 Nevertheless, in that study we did not analyse the CD8 T cell subset, which is critically altered in age-related immunosenescence. 20 On the other hand, we also did not evaluate whether the cause of the thymic impairment could be a reduction in haematopoietic progenitors. In this study, our main goals were to more thoroughly examine these questions and to extend the knowledge about scarce CD4 T cell restoration under suppressive HAART.
Patients and methods

Subjects
A cross-sectional study was performed in a cohort of HIV-1-infected subjects from the Infectious Diseases Service at the Virgen del Rocío University Hospital, Spain. The LLR group comprised 21 consecutive and asymptomatic HIV-infected subjects that: (i) had started HAART with CD4 T cells ,200 cells/mm 3 ; (ii) maintained an undetectable viral load (,50 HIV RNA copies/mL) for ≥2 years; 5 and (iii) after that period still maintained CD4 T cells ,250 cells/mm 3 . For comparison, 20 consecutive and asymptomatic HIV-infected subjects following the criteria in (i) and (ii), but overcoming the threshold for CD4 T cells defined in (iii) were considered as the CD4 T cell repopulation (R) group. Both groups of HIV-infected subjects were also compared with 14 age-matched healthy subjects (HS). For the analysis performed in fresh blood samples, all HS but only 15 subjects from each HIV-infected group were available. Written informed consent was obtained from all subjects and the Ethics Committee of the Hospital approved this study.
Laboratory measurements
The absolute numbers of CD4 and CD8 T cells were determined in fresh blood with an Epics XL-MCL flow cytometer (Beckman Coulter). Plasma HIV-1 RNA levels were measured by quantitative PCR (COBAS Ampliprep/COBAS Taqman HIV-1 test, Roche Molecular Systems), according to the manufacturer's instructions. The detection limit for this assay was 40 HIV RNA copies/mL. Plasma samples were tested for hepatitis B virus (HBV)-related markers [hepatitis B surface antigen (HBsAg)] using an HBV ELISA (Siemens Healthcare Diagnosis). Hepatitis C virus (HCV) RNA was detected by a commercially available PCR procedure (COBAS Amplicor, Roche Diagnosis, Barcelona, Spain) with a detection limit of 15 IU/mL. An immunoturbidimetric assay was performed for the quantitative determination of high-sensitivity C-reactive protein (hsCRP) in sera using Roche automated clinical chemistry analysers, according to the manufacturer's instructions.
Immunophenotyping
All cellular immunophenotyping was performed on fresh blood samples, which were partially processed by the HIV BioBank. 21 We designed several five-parametric panels for the cellular characterization of different CD4 and CD8 T cell subpopulations, which required previous CD4 and CD8 T cell isolation. Peripheral CD4 and CD8 T cell subsets were positively selected from fresh peripheral blood mononuclear cells (PBMCs) using magnetic microbeads from MACS w Cell Separation Reagents (Miltenyi Biotec, Germany), according to the manufacturer's instructions. The isolated CD4+ and CD8+ T cells were then stained using the following different monoclonal antibodies: CD45RO-PECy7, Ki67-PE (Becton Dickinson, San Jose, CA, USA); CD45RA-ECD, CD27-PECy5, CD57-FITC, CD28-PE, CD38-PE and HLA-DR-PECy5 (Beckman Coulter, FL, USA). Both CD4 and CD8 T cell subsets were defined as follows: naive (CD45RA+CD27+); memory (CD45RO+CD27+); effector memory (CD45RO+CD272); and effector memory RA+ (T EM RA) (CD45RA+CD272). The accuracy of these phenotypes has recently been reported. 22 To identify activated T cells, HLA-DR and/or CD38 were used. Senescent T cells were characterized as CD282CD57+. Proliferation levels were determined by intracellular immunostaining for Ki67. Cells were permeabilized using the fixation/permeabilization staining set (eBioscience), according to the manufacturer's instructions. Freshly isolated PBMCs were also immunophenotyped using CD127-PE and CD4-ECD (Beckman Coulter) to identify levels of the IL-7 receptor. Data on a minimum of 100000 events were acquired. Human peripheral blood haematopoietic progenitors were quantified in frozen samples of human peripheral mononuclear cells by multicolour flow cytometry using the following antibodies: CD34-PE (Miltenyi Biotec, Germany), CD45RA-ECD and CD3-PC7 (Beckman Coulter, FL, USA). An average of 200000 events was collected for the analysis of haematopoietic progenitors. Acquisition and analysis were performed on a Cytomics FC500 flow cytometer (five channels) and with CXP software (Beckman Coulter), respectively.
Determination of serum sCD14
sCD14 levels were quantified in frozen serum samples using an ELISA assay (Diaclone, Besançon, France), according to the manufacturer's instructions.
Statistical analysis
All continuous variables were expressed as a median for each variable (IQR), and the categorical variables as the number of cases and percentages. Differences among categorical variables were analysed using the x 2 test. Differences among continuous variables were analysed using the Mann-Whitney U-test to compare parameters between both LLR and R groups and healthy volunteers. Correlations between quantitative parameters were explored using the Spearman's r correlation coefficient test. Statistical analysis was performed using the Statistical Package for the Social Sciences software (SPSS 17, Chicago, IL, USA). A P value ,0.05 was considered statistically significant; however, P values between 0.05 and 0.2 are also shown.
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Results
Patient characteristics
Twenty-one LLR patients, 20 R patients and 14 HS were included in this study. All subjects were Caucasian. Clinical and demographic characteristics are shown in Table 1 . LLR and R patients were similar in age and gender. As expected, LLR patients displayed significantly lower median CD4 T cell counts (absolute and percentage) compared with both the R group and the HS. No differences were found in the route of transmission between the HIV-infected groups (data not shown). Surprisingly, the R group showed a trend toward having undergone more AIDS-defining events prior to starting suppressive HAART therapy. A comprehensive comparative analysis of HIV infection history and antiretroviral treatment was performed ( Table 2) . Only two significant differences between the groups were found: a trend toward more protease inhibitor-including regimens and significantly fewer viral load rebounds after classification in the LLR patients.
We also compared patients included in the fresh T cell immunophenotyping analysis (n¼15 from each HIV-infected group) to corroborate that the global results (containing all subjects) were still applicable to this reduced population. No significant differences were observed when compared with the global analysis (data not shown); however, it is of interest to note that there was higher similarity in the nadir of the CD4 T cell levels in the two groups [41 (13- 
Analysis of immunological parameters
We performed an exhaustive CD4 and CD8 T cell phenotypic analysis in 15 patients from each HIV-infected group and 13 HS (Table 3 ). In the CD4 lymphocyte subset, the frequency of naive T cells was significantly decreased in LLR patients when compared with both the R group and HS. Furthermore, these naive CD4 T cells showed significantly higher expression of activation, senescence and proliferation markers in the LLR group compared with the R patients ( Figure 1 ). In contrast, a significant increase of effector memory CD4 T cells and T EM RA CD4 T cells was observed in the LLR group compared with the R patients ( Figure 2a) .
The frequency of the naive CD8 T cell subset was also lower in the LLR group compared with the R patients, although without any of the phenotypic alterations of homeostasis. Moreover, the effector memory CD8 T cells showed a significant expansion in the LLR when compared with the R patients ( Figure 2b ). Interestingly, memory, effector memory and T EM RA CD8 T cells of LLR patients showed lower markers of senescence than those of the R group. This lower expression was also true for these subsets (except for the T EM RA subpopulation) for the cellular activation marker HLA-DR. As others have reported, 10, 23 no differences in cellular activation were observed when the CD38 marker was used in either the CD4 or the CD8 T cell subsets (Table 3) .
Consistent with our hypothesis, a significant positive correlation between the CD4 T cell count and the naive CD4 T cell frequency (r ¼ 0.477, P ¼ 0.002) was observed. Additionally, significant negative correlations were found between the absolute Méndez-Lagares et al. 
Frequency of CD341 precursors
The frequency of haematopoietic precursors was analysed in 12 patients from each HIV-infected group. No differences in the percentages of CD34+ or CD34+CD45RA+ T cells were observed between LLR and R patients [1.40% (0.88% -2.45%) versus 1.60% (1.23% -2.48%), P ¼ 0.525; and 0.48% (0.41% -0.87%) versus 0.70% (0.47% -1.06%), P ¼ 0.248, respectively]. Moreover, because several studies suggest that human haematopoietic progenitors, which are committed to generate mature thymocytes that might possibly seed the thymus, could possess a CD34hiCD45RA+ phenotype, 24 -27 we also compared the percentages of CD34hi and CD34hiCD45RA+ cells without finding any differences between either HIV-infected group [0.18% (0.07% -0.26%) versus 0.19% (0.14% -0.28%), P ¼ 0.470; and 0.03% (0.02% -0.06%) versus 0.03% (0.02% -0.04%), P ¼ 0.419, respectively]. The percentages of total CD34+ cells were also similar between the HIV-infected groups (data not shown).
Expression of the IL-7 receptor
We analysed the frequency of CD4+CD127+ T cells by flow cytometry. No differences were found between LLR and R patients 
Serum sCD14 levels
Because sCD14 has been independently associated with mortality in HIV infection 17 and low-level CD4 T cell repopulation patients show an enhanced risk of death, 3 -5 we wondered whether these patients would show increased levels of this marker. Our results indicated higher sCD14 levels in both HIV-infected groups compared with the HS group. However, similar levels of sCD14 were observed between LLR and R patients (Figure 3 ). Positive correlations were observed between sCD14 levels and HLA-DR+ effector memory and T EM RA CD4 T cells and T EM RA CD8 T cells, as well as with CD38+HLA-DR+ T EM RA CD8 (data not shown). Furthermore, our results also confirmed the previously reported 28, 29 correlation between sCD14 and activated CD8 T cells (CD38+HLA-DR+) (r¼ 0.455, P¼ 0.006).
The sCD14 levels negatively correlated with the time on pre-HAART or HAART (r¼ 20.364, P ¼ 0.021; and r¼ 20.342, P ¼ 0.031, respectively). The unexpected result of similar sCD14 levels in both HIV-infected groups encouraged us to explore sCD14 levels at the time of suppressor HAART initiation (a median 3.5 years before this study). No differences were found in either pre-treatment sCD14 levels or between timepoints among any HIV-infected group (Figure 3 ).
Inflammatory hsCRP
Because cellular activation and systemic inflammation could be interconnected through cellular mediators, we wondered whether low-level CD4 T cell repopulation patients, who have heightened immune activation, would show increased levels of the proinflammatory mediator hsCRP. No differences were found in the hsCRP levels between LLR and R patients or HS (Figure 4a ). We then stratified the hsCRP values as higher or lower than 2 mg/mL, a level that had previously been reported as having clinical significance for cardiovascular events. 30 We observed that the LLR group showed a tendency to have more subjects with hsCRP levels .2 mg/mL when compared with (Figure 4b ). No correlation was observed between the hsCRP levels and the CD4 T cell count (or CD4 T cell nadir) (data not shown).
Discussion
Our results showed that HIV-infected patients with low-level CD4 T cell restoration under suppressive HAART (LLR patients) suffer Low CD4 restoration on suppressive HAART important homeostatic alterations in their naive CD4 T cell subset and an accumulation of effector memory CD4 and CD8 T cells. These alterations seem not to be related to a lower frequency of CD34+ haematopoietic precursors. Additionally, levels of sCD14 were not specifically altered in these patients.
We have previously reported a reduced thymic function in LLR patients 2 by using the d/b T cell receptor excision circles ratio quantification. 31 In addition, we proposed a model whereby this thymic impairment could favour the marked damage of circulating CD4 T cells. 2 We have now extended the knowledge about which T cell subpopulations are directly perturbed by this peripheral erosion. We found that naive CD4 T cells, but no other T cell subset, are hyperactivated, proliferating and senescent. The higher proliferation in this subset does not necessarily argue against the low CD4 T cell restoration in these patients, since other factors are probably affecting the survival of these cells 8, 16 or controlling such homeostatic compensatory expansion. 32 Additionally, we have observed a clear accumulation of both effector memory and T EM RA CD4 T cells and effector memory CD8 T cells in LLR patients. In agreement with this hypothesis, it has been suggested that there is a highly differentiated maturation profile in these patients, which may affect T lymphocyte function and, consequently, CD4 T cell restoration. 23, 33 Both naive CD4 and CD8 T cell subsets were reduced in LLR patients. This fact can be partially explained by the thymic failure and has been corroborated by other studies. 13, 23, 33 Despite the fact that our results corroborate our previous hypothesis of a premature immunosenescence in LLR patients, 2 we did not observe homeostatic alterations affecting the naive CD8 T cells, which are extensively altered in age-related immunosenescence. 20, 34 Important clinical consequences could be derived from these results, because LLR patients already show naive CD4 T cell-related homeostatic alterations and because they will probably also acquire naive CD8 T cell-related alterations due to the process of ageing.
In addition to our previous data on thymic impairment, we have now explored the frequency of primitive precursor cells. Our results suggest that the thymic impairment in these patients is likely due to a subsequent deficiency in intrathymic differentiation, which involves the differentiation capacity of CD34+ progenitors and/or thymic stromal failure. In this context, Isgrò et al. 35 have found an altered clonogenic capability of haematopoietic progenitors. However, a limitation to this hypothesis is that the precise phenotype of the T cell progenitor has not yet been firmly established. In fact, the phenotype of those progenitors that physiologically seed the thymus from the blood remains unknown, 24 although the presence of a human circulating postnatal progenitor capable of seeding the thymus has been described. 36 IL-7 increases in lymphopenic scenarios, possibly involved in both the tentative support of thymic output and the induction of peripheral T cell turnover. 37 -39 In LLR patients, higher plasma IL-7 levels have been previously reported, 13, 14 although it is not clear whether this merely reflects less consumption due to a highly depleted T cell pool rather than a directly increased production of the cytokine. Nevertheless, contradictory results have been reported regarding IL-7 receptor (IL-7R) Méndez-Lagares et al.
expression. 13, 14 Our results show similar IL-7R expression in the CD4 T cell subset of LLR and R patients, suggesting that CD4 T cells of LLR patients do not increase their IL-7 consumption ability through an increase in receptor expression, despite it being reasonable to expect such an increase as a compensatory mechanism. Further studies are needed to clarify why T cell restoration in these patients is not improved by the physiological increase of IL-7 levels. Assuming that naive CD4 T cell-associated homeostatic erosion occurs, a possible failure could be speculated about the subsequent IL-7 intracellular signalling by these cells. It has been recently described that sCD14 predicts mortality in HIV infection. 17 In this report, it was considered that sCD14 could better reflect the host response to the microbial product rather than the microbial translocation itself. Our results show significantly increased sCD14 levels in all HIV-infected patients when compared with healthy subjects, but contrary to what was expected, sCD14 was not specifically increased in LLR patients. We speculate that sCD14 levels could be more related to the severe immunosuppression reached by both groups prior to beginning HAART (,200 CD4 cells/mm 3 ), because both HIV-infected groups had similar levels at this point. Alternatively, it has been proposed that sCD14 could directly reflect translocated bacterial products. 19 From this perspective, we could also hypothesize that the highly immunosuppressive status of both HIV-infected groups, at the moment of HAART initiation, could have similarly compromised the permeability of the gut-associated lymphoid tissue and that further antiretroviral treatment was not able to repair such critical damage. In any case, considering the clinical value of sCD14 in predicting mortality in HIV infection, our data could have important clinical consequences; it is likely that starting a suppressor HAART regimen with ,200 CD4 cells/mm 3 will result in severe immune damage that could persist even after a normal CD4 T cell restoration under suppressor HAART. Other authors have described higher levels of sCD14 in discordant rather than concordant patients. 16 However, none of those HIV-infected groups was severely immunosuppressed prior to entering HAART.
A limitation of our study is the relatively small number of patients. However, our patients were highly characterized and were subject to strict selective criteria, and the clinical value of these criteria has been corroborated in epidemiological studies showing their increased risk of death. 3 -5 Furthermore, performing analysis on fresh blood samples also limited the availability of the patients' samples. In contrast, our design does not allow the interpretation of whether all these alterations are a direct cause or a result of the poor CD4 T cell recovery by these patients.
We conclude that patients who persistently maintain low CD4 T cells despite suppressor HAART have important homeostatic alterations that are compatible with a model of intrinsic thymic failure and specific features of premature immunosenescence. The clinical consequences for these patients of the immunosenescence related to ageing, which will appear in the next two decades, are uncertain. 
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